Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001178913-17-001008
Filing Date
2017-03-31
Accepted
2017-03-31 16:04:18
Documents
40
Period of Report
2016-12-31

Document Format Files

Seq Description Document Type Size
1 10-K zk1719723.htm 10-K 716308
2 EXHIBIT 31.1 exhibit_31-1.htm EX-31.1 9424
3 EXHIBIT 31.2 exhibit_31-2.htm EX-31.2 9563
4 EXHIBIT 32.1 exhibit_32-1.htm EX-32.1 6065
11 image00001.jpg GRAPHIC 86678
  Complete submission text file 0001178913-17-001008.txt   2127877

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT inks-20161231.xml EX-101.INS 206047
6 XBRL TAXONOMY EXTENSION SCHEMA inks-20161231.xsd EX-101.SCH 23430
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE inks-20161231_cal.xml EX-101.CAL 29447
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE inks-20161231_def.xml EX-101.DEF 54901
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE inks-20161231_lab.xml EX-101.LAB 182207
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE inks-20161231_pre.xml EX-101.PRE 126808
Mailing Address 18 EAST 16TH STREET NEW YORK NY 10003
Business Address 18 EAST 16TH STREET NEW YORK NY 10003 646-233-1454
Artemis Therapeutics, Inc. (Filer) CIK: 0001062128 (see all company filings)

EIN.: 841417774 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-24431 | Film No.: 17730323
SIC: 2890 Miscellaneous Chemical Products